• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期起病的脊髓性肌萎缩症中的脂肪酸氧化异常:原发性还是继发性缺陷?

Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?

作者信息

Tein I, Sloane A E, Donner E J, Lehotay D C, Millington D S, Kelley R I

机构信息

Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Pediatr Neurol. 1995 Jan;12(1):21-30. doi: 10.1016/0887-8994(94)00100-g.

DOI:10.1016/0887-8994(94)00100-g
PMID:7748356
Abstract

The purpose of this study was to further identify and quantify the fatty acid oxidation abnormalities in spinal muscular atrophy, correlate these with disease severity, and identify specific underlying defect(s). Fifteen children with spinal muscular atrophy (3 type I, 8 type II, 4 type III) were studied. Serum carnitine total/free ratios demonstrated a tendency toward an increased esterified fraction ranging 35-58% of total carnitine (normal: 25-30% of total) in younger children with types I and II. The remaining type II and III patients, older than 23 months of age at sampling, had normal esterified carnitine levels. Urinary organic acid analysis demonstrated mild to moderate medium-chain dicarboxylic aciduria in type I patients and normal, mild, or moderate increases in short-chain and medium-chain organic acids in type II patients. In the type III group, the organic acids were normal except for one patient with mild medium-chain dicarboxylic aciduria. Muscle intramitochondrial beta-oxidation was measured in 5 children (2 type I, 2 type II, and 1 type III) and a significant reduction in the activities of short-chain L-3-hydroxyacyl-CoA dehydrogenase, long-chain L-3-hydroxyacyl-CoA dehydrogenase, acetoacetyl-CoA thiolase, and 3-ketoacyl-CoA thiolase were found; however, normal crotonase activity was documented. Most strikingly, there was a marked increase (3- to 5-fold) in the activity ratios of crotonase to L-3-hydroxyacyl-CoA dehydrogenase and thiolase activities with both short- and long-chain substrates. The combined abnormalities suggest a defect in a mitochondrial multifunctional enzyme complex, distinct from the trifunctional enzyme. These abnormalities may be either primary or secondary and may respond to dietary measures to reduce the dependence on fatty acid oxidation.

摘要

本研究的目的是进一步识别和量化脊髓性肌萎缩症中脂肪酸氧化异常,将这些异常与疾病严重程度相关联,并确定具体的潜在缺陷。对15名脊髓性肌萎缩症患儿(3名I型、8名II型、4名III型)进行了研究。血清肉碱总/游离比值显示,I型和II型的年幼儿童中,酯化部分有增加的趋势,占总肉碱的35 - 58%(正常:占总肉碱的25 - 30%)。其余II型和III型患者在采样时年龄超过23个月,其酯化肉碱水平正常。尿有机酸分析显示,I型患者有轻度至中度的中链二羧酸尿症,II型患者短链和中链有机酸有正常、轻度或中度增加。在III型组中,除一名有轻度中链二羧酸尿症的患者外,有机酸均正常。对5名儿童(2名I型、2名II型和1名III型)的肌肉线粒体内β-氧化进行了测量,发现短链L-3-羟基酰基辅酶A脱氢酶、长链L-3-羟基酰基辅酶A脱氢酶、乙酰乙酰辅酶A硫解酶和3-酮酰基辅酶A硫解酶的活性显著降低;然而,巴豆酸酶活性记录正常。最显著的是,巴豆酸酶与L-3-羟基酰基辅酶A脱氢酶的活性比值以及短链和长链底物的硫解酶活性均有显著增加(3至5倍)。这些综合异常表明线粒体多功能酶复合物存在缺陷,不同于三功能酶。这些异常可能是原发性的或继发性的,可能对饮食措施有反应,以减少对脂肪酸氧化的依赖。

相似文献

1
Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?儿童期起病的脊髓性肌萎缩症中的脂肪酸氧化异常:原发性还是继发性缺陷?
Pediatr Neurol. 1995 Jan;12(1):21-30. doi: 10.1016/0887-8994(94)00100-g.
2
Combined enzyme defect of mitochondrial fatty acid oxidation.线粒体脂肪酸氧化联合酶缺陷
J Clin Invest. 1992 Oct;90(4):1219-25. doi: 10.1172/JCI115983.
3
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.利用替代前体和成纤维细胞中的酰基肉碱谱分析对长链脂肪酸氧化障碍进行鉴别诊断。
Mol Genet Metab. 2006 Jan;87(1):40-7. doi: 10.1016/j.ymgme.2005.09.018. Epub 2005 Nov 16.
4
3-Hydroxydicarboxylic and 3-ketodicarboxylic aciduria in three patients: evidence for a new defect in fatty acid oxidation at the level of 3-ketoacyl-CoA thiolase.三名患者出现3-羟基二羧酸和3-酮二羧酸尿症:3-酮酰基辅酶A硫解酶水平上脂肪酸氧化新缺陷的证据。
Clin Chem. 1993 May;39(5):897-901.
5
Combined defect of long-chain 3-hydroxyacyl-CoA dehydrogenase, 2-enoyl-CoA hydratase and 3-oxoacyl-CoA thiolase.长链3-羟基酰基辅酶A脱氢酶、2-烯酰基辅酶A水合酶和3-氧代酰基辅酶A硫解酶联合缺陷
Prog Clin Biol Res. 1992;375:327-37.
6
Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation.人类三功能蛋白缺乏症:一种线粒体脂肪酸β氧化的新疾病。
Biochem Biophys Res Commun. 1992 Nov 16;188(3):1139-45. doi: 10.1016/0006-291x(92)91350-y.
7
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.胎儿脂肪酸氧化障碍作为孕妇肝病的一个病因
N Engl J Med. 1999 Jun 3;340(22):1723-31. doi: 10.1056/NEJM199906033402204.
8
Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients.线粒体三功能蛋白缺乏症。两名患者中突变酶的催化异质性。
J Clin Invest. 1994 Apr;93(4):1740-7. doi: 10.1172/JCI117158.
9
Clinical and biochemical features of fatty acid oxidation disorders.脂肪酸氧化障碍的临床和生化特征。
Curr Opin Pediatr. 1998 Dec;10(6):615-21. doi: 10.1097/00008480-199810060-00014.
10
Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.心律失常和传导缺陷作为儿童脂肪酸氧化障碍的首发症状。
Circulation. 1999 Nov 30;100(22):2248-53. doi: 10.1161/01.cir.100.22.2248.

引用本文的文献

1
Comorbidities in spinal muscular atrophy and their impact on the course of the underlying disease: a real-life observational study.脊髓性肌萎缩症的合并症及其对基础疾病病程的影响:一项真实世界观察性研究
BMC Musculoskelet Disord. 2025 Sep 2;26(1):839. doi: 10.1186/s12891-025-09133-6.
2
Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.肌萎缩侧索硬化症和脊髓性肌萎缩症中脂肪和酮体代谢的改变——一项前瞻性观察研究
Eur J Neurol. 2025 Apr;32(4):e70132. doi: 10.1111/ene.70132.
3
Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA.
在脊髓性肌萎缩症小鼠模型中,心脏功能的改变与脂肪酸代谢紊乱相关。
Hum Mol Genet. 2025 Mar 7;34(6):547-562. doi: 10.1093/hmg/ddaf006.
4
Glucose and Lipid Metabolism Disorders in Adults with Spinal Muscular Atrophy Type 3.3型脊髓性肌萎缩症成人患者的糖脂代谢紊乱
Diagnostics (Basel). 2024 Sep 19;14(18):2078. doi: 10.3390/diagnostics14182078.
5
Non-diabetic Euglycemic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II.一名成年II型脊髓性肌萎缩症患者的非糖尿病正常血糖性酮症酸中毒
Cureus. 2023 Sep 21;15(9):e45666. doi: 10.7759/cureus.45666. eCollection 2023 Sep.
6
SMN Deficiency Destabilizes ABCA1 Expression in Human Fibroblasts: Novel Insights in Pathophysiology of Spinal Muscular Atrophy.运动神经元存活 1 号基因缺失导致人成纤维细胞中 ABCA1 表达不稳定:脊髓性肌萎缩症发病机制的新见解。
Int J Mol Sci. 2023 Feb 2;24(3):2916. doi: 10.3390/ijms24032916.
7
Mitochondrial Dysfunction in Spinal Muscular Atrophy.脊髓性肌萎缩症中的线粒体功能障碍。
Int J Mol Sci. 2022 Sep 17;23(18):10878. doi: 10.3390/ijms231810878.
8
Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental Therapies.婴儿和儿童脊髓性肌萎缩症的药物治疗:已批准和实验性治疗的综述。
Paediatr Drugs. 2022 Nov;24(6):585-602. doi: 10.1007/s40272-022-00529-8. Epub 2022 Aug 27.
9
Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1.脊髓性肌萎缩症 1 型患儿管理中的营养、胃肠道和代谢问题。
Nutrients. 2021 Jul 13;13(7):2400. doi: 10.3390/nu13072400.
10
Genomic Variability in the Survival Motor Neuron Genes ( and ): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development.生存运动神经元基因(和 )中的基因组变异性:对脊髓性肌萎缩症表型和治疗学发展的影响。
Int J Mol Sci. 2021 Jul 23;22(15):7896. doi: 10.3390/ijms22157896.